0,961  0,004  Antineoplastic (lung cancer)
0,927  0,002  Topoisomerase II inhibitor
0,904  0,005  Antineoplastic (breast cancer)
0,894  0,004  Antineoplastic (colon cancer)
0,894  0,004  Antineoplastic (colorectal cancer)
0,891  0,004  Antineoplastic (lymphocytic leukemia)
0,876  0,004  Antineoplastic (cervical cancer)
0,866  0,004  Prostate cancer treatment
0,862  0,004  Antineoplastic (non-small cell lung cancer)
0,853  0,004  Antineoplastic (carcinoma)
0,849  0,003  Caspase 3 stimulant
0,834  0,003  Antineoplastic (squamous cell carcinoma)
0,837  0,012  Apoptosis agonist
0,824  0,005  Antineoplastic (ovarian cancer)
0,823  0,005  Antileukemic
0,820  0,003  DNA damaging
0,812  0,004  Tubulin antagonist
0,804  0,005  Antineoplastic (melanoma)
0,798  0,004  Antineoplastic (glioma)
0,783  0,004  Antineoplastic (glioblastoma multiforme)
0,774  0,004  Antimitotic
0,735  0,004  Antineoplastic (renal cancer)
0,723  0,005  Antineoplastic (brain cancer)
0,720  0,002  Topoisomerase II alpha inhibitor
0,702  0,004  Antineoplastic (multiple myeloma)
0,719  0,022  Caspase 9 stimulant
0,685  0,003  Alpha tubulin antagonist
0,681  0,004  DNA intercalator
0,679  0,004  Hepatoprotectant
0,674  0,003  Carcinogenic, group 1
0,656  0,009  Cytostatic
0,649  0,005  Genotoxic
0,636  0,004  Antineoplastic (small cell lung cancer)
0,655  0,025  Transcription factor NF kappa B inhibitor
0,632  0,005  Antineoplastic (sarcoma)
0,629  0,003  Topoisomerase I inhibitor
0,629  0,002  Carcinogenic, group 2A
0,637  0,015  Antineoplastic (solid tumors)
0,605  0,005  Antineoplastic (lymphoma)
0,591  0,012  Hepatic disorders treatment
0,551  0,004  Beta tubulin antagonist
0,533  0,012  Hypoxia-inducible factor 1 alpha inhibitor
0,527  0,018  CYP2C19 inhibitor
0,510  0,017  NOS2 expression inhibitor
0,470  0,002  Topoisomerase II beta inhibitor
0,481  0,021  Chemopreventive
0,449  0,005  Antineoplastic (bone cancer)
0,443  0,016  Antineoplastic (osteosarcoma)
0,443  0,040  Ulceration
0,438  0,036  Antihypercholesterolemic
0,449  0,051  CYP3A4 substrate
0,418  0,024  Antipyretic
0,393  0,008  Alkylator
0,376  0,003  Keratolytic
0,400  0,040  CYP1A2 substrate
0,382  0,024  Pyruvate kinase inhibitor
0,383  0,026  Antineoplastic (liver cancer)
0,391  0,040  Antineoplastic (pancreatic cancer)
0,379  0,036  Sensitization
0,378  0,038  CYP3A4 inhibitor
0,337  0,017  Melanin inhibitor
0,385  0,070  Immunosuppressant
0,363  0,049  Vasodilator, coronary
0,337  0,045  Cytotoxic
0,371  0,088  15-Lipoxygenase inhibitor
0,335  0,060  5 Hydroxytryptamine release stimulant
0,290  0,021  Neurotrophic factor enhancer
0,298  0,029  P-glycoprotein inhibitor
0,315  0,049  Radiosensitizer
0,261  0,006  Microtubule formation inhibitor
0,308  0,066  Antineoplastic (endocrine cancer)
0,285  0,043  Nitric oxide antagonist
0,312  0,071  Respiratory analeptic
0,239  0,005  Antineoplastic alkaloid
0,245  0,014  Phobic disorders treatment
0,267  0,038  VCAM1 expression inhibitor
0,226  0,006  Postmenopausal disorders treatment
0,286  0,067  Antioxidant
0,298  0,081  12-Lipoxygenase inhibitor
0,231  0,031  LDLR expression enhancer
0,317  0,119  TNF expression inhibitor
0,245  0,049  Abortion inducer
0,263  0,067  Proliferative diseases treatment
0,286  0,098  ICAM1 expression inhibitor
0,190  0,009  Electron transport complex I inhibitor
0,217  0,041  Antiviral (Herpes)
0,184  0,009  CDC-like kinase 3 inhibitor
0,251  0,092  CYP2C19 substrate
0,257  0,099  NOS3 expression inhibitor
0,191  0,036  Acetylcholinesterase inhibitor
0,216  0,060  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,171  0,017  DNA repair enzyme inhibitor
0,199  0,049  Liver fibrosis treatment
0,223  0,078  Cyclic AMP phosphodiesterase inhibitor
0,227  0,084  Vasodilator
0,152  0,010  Ornithine decarboxylase inhibitor
0,153  0,014  Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor
0,181  0,043  Cyclooxygenase 1 inhibitor
0,220  0,083  Free radical scavenger
0,185  0,048  Contraceptive
0,180  0,048  CDC-like kinase 1 inhibitor
0,181  0,050  Protein kinase stimulant
0,240  0,111  Analeptic
0,166  0,038  MAP kinase kinase 4 inhibitor
0,128  0,004  Endothelin receptor antagonist
0,219  0,096  DNA synthesis inhibitor
0,202  0,082  Antihypertriglyceridemic
0,150  0,031  Antineoplastic antibiotic
0,131  0,014  ATPase (Vacuolar H+) inhibitor
0,225  0,111  UGT2B4 substrate
0,259  0,145  Antineoplastic (non-Hodgkin's lymphoma)
0,189  0,075  Carcinogenic
0,161  0,051  Antifungal enhancer
0,132  0,029  Calcium antagonist
0,222  0,120  Lipoxygenase inhibitor
0,195  0,094  Embryotoxic
0,101  0,004  Endothelin B receptor antagonist
0,099  0,004  Endothelin A receptor antagonist
0,113  0,023  Phosphodiesterase 11A inhibitor
0,113  0,023  Phosphodiesterase XI inhibitor
0,183  0,099  Cardiodepressant
0,109  0,027  Antiprotozoal activity enhancer
0,201  0,122  Radioprotector
0,172  0,093  Non-steroidal antiinflammatory agent
0,124  0,048  Estrogen antagonist
0,126  0,052  Antifungal (Pneumocystis)
0,248  0,175  Antineoplastic (myeloid leukemia)
0,219  0,148  Cholesterol antagonist
0,088  0,019  Glutamate (mGluR7) antagonist
0,200  0,132  Antineoplastic (bladder cancer)
0,131  0,066  Cyclooxygenase 3 inhibitor
0,155  0,091  UGT2B10 substrate
0,141  0,078  Acaricide
0,132  0,069  Skin whitener
0,155  0,093  ATPase inhibitor
0,170  0,111  Teratogen
0,140  0,085  Heat shock protein 90 antagonist
0,122  0,067  Contraceptive female
0,136  0,087  Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor
0,104  0,057  Estrogen receptor beta antagonist
0,140  0,093  Sigma receptor agonist
0,135  0,091  Cholinergic
0,122  0,079  Antineoplastic (uterine cancer)
0,235  0,192  Antibacterial
0,142  0,101  Interleukin 6 antagonist
0,220  0,180  Histamine release inhibitor
0,075  0,036  HIV-1 integrase (3'-Processing) inhibitor
0,186  0,147  CYP1A2 inhibitor
0,210  0,173  GST M1-1 substrate
0,161  0,124  Pneumotoxic
0,070  0,034  Protease activated receptor antagonist
0,160  0,126  Antiparkinsonian, rigidity relieving
0,062  0,029  Estrogen agonist
0,149  0,117  Psychostimulant
0,186  0,156  CYP2D6 substrate
0,092  0,064  Breast cancer-resistant protein inhibitor
0,095  0,070  Alpha 2c adrenoreceptor antagonist
0,113  0,088  Cyclooxygenase 2 inhibitor
0,110  0,085  Alcohol dehydrogenase substrate
0,183  0,159  Transcription factor STAT3 inhibitor
0,072  0,050  Phosphodiesterase V inhibitor
0,214  0,193  Calcium channel activator
0,128  0,106  Adenylate cyclase stimulant
0,074  0,058  Antitreponemal
0,110  0,094  Phosphodiesterase inhibitor
0,050  0,034  Factor III inhibitor
0,116  0,101  UGT2B15 substrate
0,142  0,129  UGT1A1 substrate
0,057  0,045  Heat shock protein 90 beta antagonist
0,110  0,099  Antimutagenic
0,053  0,047  HIV-1 integrase (Strand Transfer) inhibitor
0,183  0,177  AR expression inhibitor
0,135  0,130  Lipocortins synthesis antagonist
0,056  0,052  Ryanodine receptor antagonist
0,078  0,074  T cell inhibitor
0,113  0,111  Psychosexual dysfunction treatment
0,062  0,062  Telomerase inhibitor

